Next Article in Journal
Cellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease
Previous Article in Journal
Synthesis and Study of New Quinolineaminoethanols as Anti-Bacterial Drugs
Previous Article in Special Issue
CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessReview

CDK8-Novel Therapeutic Opportunities

Institute of Pharmacology and Toxicology, University of Veterinary Medicine, 1210 Vienna, Austria
Author to whom correspondence should be addressed.
Pharmaceuticals 2019, 12(2), 92;
Received: 10 May 2019 / Revised: 11 June 2019 / Accepted: 17 June 2019 / Published: 19 June 2019
(This article belongs to the Special Issue Protein Kinases and Cancer)
PDF [1351 KB, uploaded 19 June 2019]
  |     |  


Improvements in cancer therapy frequently stem from the development of new small-molecule inhibitors, paralleled by the identification of biomarkers that can predict the treatment response. Recent evidence supports the idea that cyclin-dependent kinase 8 (CDK8) may represent a potential drug target for breast and prostate cancer, although no CDK8 inhibitors have entered the clinics. As the available inhibitors have been recently reviewed, we focus on the biological functions of CDK8 and provide an overview of the complexity of CDK8-dependent signaling throughout evolution and CDK8-dependent effects that may open novel treatment avenues. View Full-Text
Keywords: CDK8; mediator complex; cancer CDK8; mediator complex; cancer

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Menzl, I.; Witalisz-Siepracka, A.; Sexl, V. CDK8-Novel Therapeutic Opportunities. Pharmaceuticals 2019, 12, 92.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top